Yahoo

Astrazeneca says Forxiga combination beats use of drug alone

A sign is seen at an AstraZeneca site in Macclesfield, central England May 19, 2014. REUTERS/Phil Noble FRANKFURT (Reuters) - AstraZeneca said combining its Forxiga type-2 diabetes drug with older ...
BioWorld

Astrazeneca to withdraw diabetes drug Forxiga from Korea

Astrazeneca Korea Co. Ltd. will pull its blockbuster diabetes drug, Forxiga (dapagliflozin), from the South Korean market, a company official confirmed to BioWorld, citing “multiple factors” like ...
FiercePharma

AstraZeneca's SGLT2 contender Forxiga wins broader NICE backing, giving more U.K. patients access

Just days after winning groundbreaking coverage for a key cancer med, AstraZeneca ($AZN) on Friday notched another win from England’s cost-effectiveness watchdogs ...
FiercePharma

AstraZeneca, BMS pull Forxiga in Germany in snit over pricing

AstraZeneca ($AZN) and Bristol-Myers Squibb ($BMY) look to be feeling good about the future of their diabetes drug Forxiga. The drugmakers have yanked the diabetes ...
Seeking Alpha

AstraZeneca Forxiga approved for expanded use in EU for chronic heart failure

The European Commission (EC) approved AstraZeneca (NASDAQ:AZN) Forxiga for expanded use to treat heart failure (HF) with reduced ejection fraction (HFrEF) to cover patients across the full spectrum of ...
The Motley Fool

AstraZeneca Enters Another Major Market With This Indication

AstraZeneca has gained access to millions of potential patients with chronic kidney disease (CKD) in Japan with its new indication for Forxiga. Forxiga's sales growth is set to continue -- it was also ...
PharmaTimes

EU approves AZ/B-MS first-in-class diabetes drug Forxiga

AstraZeneca and Bristol-Myers Squibb are celebrating following the approval of their diabetes drug Forxiga in the European Union. AstraZeneca and Bristol-Myers Squibb are celebrating following the ...
The News International

Medication for diabetes leading to complications

The NHS has warned UK patients taking a commonly prescribed medication to seek urgent medical attention if they notice any of three specific symptoms. These can indicate serious complications due ...
The Motley Fool

Here's What This Label Expansion Means for AstraZeneca Investors

The EMA's approval of Forxiga for chronic kidney disease gives AstraZeneca access to millions of patients in the EU. Forxiga's efficacy and this massive potential market should help the label ...
Nasdaq

AstraZeneca's Forxiga Approved In Japan For Chronic Kidney Disease - Quick Facts

(RTTNews) - British drug major AstraZeneca (AZN.L, AZN) announced Thursday that its Japan's Ministry of Health, Labour and Welfare has approved Forxiga (dapagliflozin), a sodium-glucose cotransporter ...
Reuters

Astrazeneca says Forxiga combination beats use of drug alone

FRANKFURT (Reuters) - AstraZeneca said combining its Forxiga type-2 diabetes drug with older medicine Bydureon was more effective at controlling blood sugar levels than treatment with either drug on ...